Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): A phase 3, randomised, double-blind, placebo-controlled trial

de Yebenes, Justo Garcia, Landwehrmeyer, Bernhard, Squitieri, Ferdinando, Reilmann, Ralf, Rosser, Anne Elizabeth, Barker, Roger, Saft, Carsten, Magnet, Markus, Sword, Alastair, Rembratt, Åsa and Tedroff, Joakim 2011. Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): A phase 3, randomised, double-blind, placebo-controlled trial. The Lancet Neurology 10 (12) , pp. 1049-1057. 10.1016/S1474-4422(11)70233-2

Full text not available from this repository.
Item Type: Article
Date Type: Publication
Status: Published
Schools: Biosciences
MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG)
Medicine
Neuroscience and Mental Health Research Institute (NMHRI)
Subjects: R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
Publisher: Elsevier
ISSN: 1474-4422
Last Modified: 04 Jun 2017 03:28
URI: http://orca.cf.ac.uk/id/eprint/21729

Actions (repository staff only)

Edit Item Edit Item